Biotech9 hours ago
AstraZeneca Acquired Biotech Company EsoBiotec, for One Billion Dollars
AstraZeneca is acquiring Belgian biotech EsoBiotec for up to $1 billion to enhance its cancer therapy portfolio. EsoBiotec's innovative ENaBL platform enables rapid, cost-effective cell therapy...